... on X-ray and bone scan were well related to clinical progression of the disease and indicated a poor prognosis in the individual patient. Soft tissue métastasés most often responded well to the initial hormone treatment, but regrew only rarely during later disease progression. Changes...

...Yoichi Arai; Osamu Yoshida Prostatic carcinoma often shows different behavior in the primary site than in the métastasés after endocrine treatment. The pattern of disease progression was evaluated in prostate cancer patients. Two hundred and sixty consecutive patients were observed following...

... patients. 7 more patients reported subjective response lasting less than 2 months. The disease progressed in the remaining 7 patients. Adverse reactions were tolerable. Our results are promising and indicate that medroxyprogesterone in high doses may have an effect in therapy-resistant cases of prostatic...

...Martin C. Michel; Mark Goepel The primary treatment goal in patients with lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO) is symptom relief. However, it is also important to assess the effects of medical treatments on disease progression because this can lead...